The market for psychedelic drugs to treat mental health conditions gets a big buy signal
Eli Lilly's acquisition of psychedelic drug maker AtaiBeckley extends Big Pharma's embrace of a stigmatized class of medications for treating mental health.
The Source
CNBC
US
Boeing and Airbus prepare for next narrow-body battle – but airlines aren’t pushing for new jets yet
CNBC·1h ago·3 min read
US
U.S. strikes Iran and Houthis threaten Saudi Arabia shipping as mediators push 10-day ceasefire
CNBC·40m ago·3 min read
Business
General Motors is set to report earnings before the bell. Here’s what Wall Street expects
CNBC·5h ago·3 min read
Business
Jamie Dimon says markets underestimate risks and he wouldn’t buy stocks or Treasurys at current prices
CNBC·10h ago·3 min read
Related
On this beat
Health
The Sewer Knows What You Ate
TNYT·14h ago·3 min read
Health
They used GLP-1s to lose weight. They ended up in treatment for anorexia.
TWSJ·18h ago·3 min read
Health
The Best Genetic Risk Tools Don’t Work Equally for Everyone
TNYT·1d ago·3 min read
Health
Five cups of coffee a day is fine for most adults, heart association says, as evidence grows about the beverage’s benefits
TWSJ·1d ago·3 min read
